Unfractionated heparin (UH) is a heterogenous preparation of anionic, sulfated glycosaminoglycan polymers with weights ranging from 3000 to 30,000 Da. It is a naturally occurring anticoagulant released from mast cells. It binds reversibly to antithrombin III (ATIII) and greatly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin (fac...
Unfractionated heparin is indicated for prophylaxis and treatment of venous thrombosis and its extension, prevention of post-operative deep venous thrombosis and pulmonary embolism and prevention of clotting in arterial and cardiac surgery. In cardiology, it is used to prevent embolisms in patients with atrial fibrillation and as an adjunct antithrombin ther...
Beijing Anzhen Hospital, Capital Medical University, Beijing, China
The Christ Hospital, Cincinnati, Ohio, United States
Ain Shams University Hospitals, Cairo, Egypt
New York University School of Medicine, New York, New York, United States
Wuhan Asia Heart Hospital, Wuhan, Hubei, China
Hospital da Cidade, Salvador, Brazil
The Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada
Hospital Tacchini, Bento Gonçalves, Brazil
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.